Toshiba receives FDA OK for new cardiac flat-panel detector

Toshiba America Medical Systems Inc. has received FDA marketing clearance for the new C-panel flat-panel detector (FPD) for the Infinix CC-i vascular system.

The C-panel FPD technology is designed for high-resolution dynamic imaging for cardiovascular intervention and diagnostic exams, as well as greater flexibility for dose reduction. The C-panel FPD is a field-upgradeable component for Toshiba's Infinix CC-i system and takes about three days to complete.

With the new C-panel FPD, Toshiba says the Infinix CC-i offers a variety of frame rate options in both fluoro and record mode. The Toshiba cardiac FPD also is designed with a 20 cm by 20 cm field-of-view for cardiac imaging procedures.

Toshiba says its Infinix CC-i system is the industry's only vascular x-ray system that is field-upgradeable to FPD technology.

The Infinix CC-i also features Toshiba's new Digital Fluorography Processor 8000 (DFP-8000D) for tableside controls over image processing and data management.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.